Skip to the page

Data / Form D filings / Suono Bio, Inc.

Suono Bio, Inc.: Form D filings

Suono Bio, Inc., a biotechnology company in Foxborough, MA, filed 4 Form D notices with the SEC between 2017 and 2023. The latest, on August 28, 2023, reports $500,000 sold of a $3 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
200 FOXBOROUGH BLVD, SUITE 100, Foxborough, MA, 02035
Phone
(617) 299-1496
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1710229

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 28, 2023New notice$3,000,000$500,000$2,500,0001Aug 25, 2023sec.gov
Jul 7, 2021Amendment$15,237,250$12,176,840$3,060,41011Mar 19, 2021sec.gov
Mar 25, 2021New notice$13,737,249$6,676,839$7,060,4109Mar 19, 2021sec.gov
Jun 23, 2017New notice$2,000,000$1,300,000$700,0002Jun 20, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
CARL SCHOELLHAMMERExecutive Officer, Director
FREDERICK SHANEDirector
GIOVANNI TRAVERSODirector
VICTORIA WANGDirector
SCOTT KELLOGGExecutive Officer, Director
ROBERT LANGERDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Aug 28, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Suono Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.